Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 230

1.

Predicting the long-term outcomes of biologics in patients with psoriasis using machine learning.

Emam S, Du AX, Surmanowicz P, Thomsen SF, Greiner R, Gniadecki R.

Br J Dermatol. 2019 Nov 28. doi: 10.1111/bjd.18741. [Epub ahead of print] No abstract available.

PMID:
31778205
2.

Skin Patterning in Psoriasis by Spatial Interactions between Pathogenic Cytokines.

Ringham L, Prusinkiewicz P, Gniadecki R.

iScience. 2019 Oct 25;20:546-553. doi: 10.1016/j.isci.2019.10.008. Epub 2019 Oct 7.

3.

Clinical and Histological Characteristics of Mycosis Fungoides and Sézary Syndrome: A Retrospective, Single-centre Study of 43 Patients from Eastern Denmark.

Nielsen PR, Eriksen JO, Wehkamp U, Lindahl LM, Gniadecki R, Fogh H, Fabricius S, Bzorek M, Ødum N, Gjerdrum LM.

Acta Derm Venereol. 2019 Dec 1;99(13):1231-1236. doi: 10.2340/00015555-3351.

4.

Patient-reported Outcomes During Treatment in Patients with Moderate-to-severe Psoriasis: A Danish Nationwide Study.

Loft ND, Egeberg A, Rasmussen MK, Bryld LE, Gniadecki R, Dam TN, Iversen L, Skov L.

Acta Derm Venereol. 2019 Dec 1;99(13):1224-1230. doi: 10.2340/00015555-3331.

5.

Skin colonization by circulating neoplastic clones in cutaneous T-cell lymphoma.

Iyer A, Hennessey D, O'Keefe S, Patterson J, Wang W, Wong GK, Gniadecki R.

Blood. 2019 Oct 31;134(18):1517-1527. doi: 10.1182/blood.2019002516.

PMID:
31515249
6.

Overall Survival in Mycosis Fungoides: A Systematic Review and Meta-Analysis.

Mourad A, Gniadecki R.

J Invest Dermatol. 2020 Feb;140(2):495-497.e5. doi: 10.1016/j.jid.2019.07.712. Epub 2019 Aug 26. No abstract available.

PMID:
31465745
7.

Expression and function of Kv1.3 channel in malignant T cells in Sézary syndrome.

Hu T, Buus TB, Krejsgaard T, Nansen A, Lundholt BK, Spee P, Fredholm S, Petersen DL, Blümel E, Gluud M, Monteiro MN, Willerslev-Olsen A, Andersen MH, Straten PT, Met Ö, Stolearenco V, Fogh H, Gniadecki R, Nastasi C, Litman T, Woetmann A, Gjerdrum LMR, Ødum N.

Oncotarget. 2019 Aug 6;10(47):4894-4906. doi: 10.18632/oncotarget.27122. eCollection 2019 Aug 6.

8.

How I learned to stop worrying about antidrug antibodies.

Gniadecki R.

Br J Dermatol. 2020 Jan;182(1):19-20. doi: 10.1111/bjd.18321. Epub 2019 Aug 12. No abstract available.

PMID:
31403173
9.

Use of Extracorporeal Photopheresis in Scleroderma: A Review.

Du AX, Osman M, Gniadecki R.

Dermatology. 2019 Jul 30:1-6. doi: 10.1159/000501591. [Epub ahead of print] Review.

10.

Immunotherapy for Cutaneous T-Cell Lymphoma: Current Landscape and Future Developments.

Sivanand A, Surmanowicz P, Alhusayen R, Hull P, Litvinov IV, Zhou Y, Gniadecki R.

J Cutan Med Surg. 2019 Sep/Oct;23(5):537-544. doi: 10.1177/1203475419867610. Epub 2019 Jul 29. Review.

PMID:
31353944
11.

A case of progressive lower leg edema.

Smylie A, Tompkins JB, Gniadecki R, Hung T.

JAAD Case Rep. 2019 Jul 12;5(7):621-623. doi: 10.1016/j.jdcr.2019.05.011. eCollection 2019 Jul. No abstract available.

12.

High-Throughput Sequencing-Based Investigation of Viruses in Human Cancers by Multienrichment Approach.

Mollerup S, Asplund M, Friis-Nielsen J, Kjartansdóttir KR, Fridholm H, Hansen TA, Herrera JAR, Barnes CJ, Jensen RH, Richter SR, Nielsen IB, Pietroni C, Alquezar-Planas DE, Rey-Iglesia A, Olsen PVS, Rajpert-De Meyts E, Groth-Pedersen L, von Buchwald C, Jensen DH, Gniadecki R, Høgdall E, Langhoff JL, Pete I, Vereczkey I, Baranyai Z, Dybkaer K, Johnsen HE, Steiniche T, Hokland P, Rosenberg J, Baandrup U, Sicheritz-Pontén T, Willerslev E, Brunak S, Lund O, Mourier T, Vinner L, Izarzugaza JMG, Nielsen LP, Hansen AJ.

J Infect Dis. 2019 Sep 13;220(8):1312-1324. doi: 10.1093/infdis/jiz318.

13.

La distinction entre le mélanome malin et d’autres lésions à l’aide de la dermoscopie.

Gniadecki R, Mourad A.

Can Fam Physician. 2019 Jun;65(6):e261-e263. French. No abstract available.

PMID:
31189639
Free PMC Article
14.

Differentiating malignant melanoma from other lesions using dermoscopy.

Gniadecki R, Mourad A.

Can Fam Physician. 2019 Jun;65(6):412-414. No abstract available. Erratum in: Can Fam Physician. 2019 Aug;65(8):531. Can Fam Physician. 2019 Aug;65(8):532.

15.

Clonotypic heterogeneity in cutaneous T-cell lymphoma (mycosis fungoides) revealed by comprehensive whole-exome sequencing.

Iyer A, Hennessey D, O'Keefe S, Patterson J, Wang W, Salopek T, Wong GK, Gniadecki R.

Blood Adv. 2019 Apr 9;3(7):1175-1184. doi: 10.1182/bloodadvances.2018027482.

16.

Oral and Intraincisional Antibiotic Prophylaxis in Mohs Surgery: A Systematic Review and Meta-analysis.

Mourad A, Gniadecki R, Taher M.

Dermatol Surg. 2019 Feb 18. doi: 10.1097/DSS.0000000000001838. [Epub ahead of print] No abstract available.

PMID:
30883482
17.

Treatment of Dactylitis and Enthesitis in Psoriatic Arthritis with Biologic Agents: A Systematic Review and Metaanalysis.

Mourad A, Gniadecki R.

J Rheumatol. 2020 Jan;47(1):59-65. doi: 10.3899/jrheum.180797. Epub 2019 Mar 1.

PMID:
30824641
18.

Clonotypic Diversity of the T-cell Receptor Corroborates the Immature Precursor Origin of Cutaneous T-cell Lymphoma.

Hamrouni A, Fogh H, Zak Z, Ødum N, Gniadecki R.

Clin Cancer Res. 2019 May 15;25(10):3104-3114. doi: 10.1158/1078-0432.CCR-18-4099. Epub 2019 Feb 26.

PMID:
30808775
19.

Macular cutaneous amyloidosis treated with methyl aminolevulinate and daylight photodynamic therapy: A case report.

Huang CM, Lam L, Gniadecki R.

SAGE Open Med Case Rep. 2019 Feb 15;7:2050313X19829617. doi: 10.1177/2050313X19829617. eCollection 2019.

20.

Factors predicting persistence of biologic drugs in psoriasis: a systematic review and meta-analysis.

Mourad A, Straube S, Armijo-Olivo S, Gniadecki R.

Br J Dermatol. 2019 Sep;181(3):450-458. doi: 10.1111/bjd.17738. Epub 2019 Apr 29. Review.

PMID:
30729500
21.

Effectiveness and safety of switching to biosimilar infliximab and etanercept in patients with psoriasis.

Lund T, Sand C, Gniadecki R, Thomsen SF.

Dermatol Ther. 2019 May;32(3):e12846. doi: 10.1111/dth.12846. Epub 2019 Feb 22. No abstract available.

PMID:
30697879
22.

Approach to the Assessment and Management of Adult Patients With Atopic Dermatitis: A Consensus Document. Section IV: Treatment Options for the Management of Atopic Dermatitis.

Dhadwal G, Albrecht L, Gniadecki R, Poulin Y, Yeung J, Hong CH, Gooderham MJ.

J Cutan Med Surg. 2018 Nov/Dec;22(1_suppl):21S-29S. doi: 10.1177/1203475418805721.

PMID:
30439301
23.

Approach to the Assessment and Management of Adult Patients With Atopic Dermatitis: A Consensus Document. Section V: Consensus Statements on the Assessment and Management of Adult Patients With Moderate-to-Severe Atopic Dermatitis.

Hong CH, Gooderham MJ, Albrecht L, Bissonnette R, Dhadwal G, Gniadecki R, Grewal P, Kirchhof MG, Landells I, Lansang P, Lynde CW, Papp KA, Poulin Y, Sussman G, Turchin I, Wiseman M, Yeung J.

J Cutan Med Surg. 2018 Nov/Dec;22(1_suppl):30S-35S. doi: 10.1177/1203475418803625.

PMID:
30439300
24.

Approach to the Assessment and Management of Adult Patients With Atopic Dermatitis: A Consensus Document.

Gooderham MJ, Hong CH, Albrecht L, Bissonnette R, Dhadwal G, Gniadecki R, Grewal P, Kirchhof MG, Landells I, Lansang P, Lynde CW, Papp KA, Poulin Y, Sussman G, Turchin I, Wiseman M, Yeung J.

J Cutan Med Surg. 2018 Nov/Dec;22(1_suppl):3S-5S. doi: 10.1177/1203475418803627.

PMID:
30439298
25.

Prescribing Home Narrowband UVB Phototherapy: A Review of Current Approaches.

Hum M, Kalia S, Gniadecki R.

J Cutan Med Surg. 2019 Jan/Feb;23(1):91-96. doi: 10.1177/1203475418800947. Epub 2018 Sep 15.

PMID:
30221998
26.

Single-cell heterogeneity in Sézary syndrome.

Buus TB, Willerslev-Olsen A, Fredholm S, Blümel E, Nastasi C, Gluud M, Hu T, Lindahl LM, Iversen L, Fogh H, Gniadecki R, Litvinov IV, Persson JL, Bonefeld CM, Geisler C, Christensen JP, Krejsgaard T, Litman T, Woetmann A, Ødum N.

Blood Adv. 2018 Aug 28;2(16):2115-2126. doi: 10.1182/bloodadvances.2018022608.

27.

CCR4-targeted therapy in cutaneous T-cell lymphoma.

Gniadecki R.

Lancet Oncol. 2018 Sep;19(9):1140-1141. doi: 10.1016/S1470-2045(18)30449-2. Epub 2018 Aug 9. No abstract available.

PMID:
30100377
28.

Long-term adalimumab efficacy in patients with moderate-to-severe hidradenitis suppurativa/acne inversa: 3-year results of a phase 3 open-label extension study.

Zouboulis CC, Okun MM, Prens EP, Gniadecki R, Foley PA, Lynde C, Weisman J, Gu Y, Williams DA, Jemec GBE.

J Am Acad Dermatol. 2019 Jan;80(1):60-69.e2. doi: 10.1016/j.jaad.2018.05.040. Epub 2018 Jun 1.

PMID:
29860040
29.

Psoriasis and risk of myocardial infarction before and during an era with biological therapy: a population-based follow-up study.

Leisner MZ, Lindorff Riis J, Gniadecki R, Iversen L, Olsen M.

J Eur Acad Dermatol Venereol. 2018 Dec;32(12):2185-2190. doi: 10.1111/jdv.15021. Epub 2018 Jul 17.

PMID:
29719939
30.

Risk of skin cancer in patients with HIV: A Danish nationwide cohort study.

Omland SH, Ahlström MG, Gerstoft J, Pedersen G, Mohey R, Pedersen C, Kronborg G, Larsen CS, Kvinesdal B, Gniadecki R, Obel N, Omland LH.

J Am Acad Dermatol. 2018 Oct;79(4):689-695. doi: 10.1016/j.jaad.2018.03.024. Epub 2018 Mar 26.

PMID:
29588249
31.

Long-term optimization of outcomes with flexible adalimumab dosing in patients with moderate to severe plaque psoriasis.

Gniadecki R, Leonardi CL, Gordon KB, Gu Y, Geng Z, Nader A, Teixeira HD.

J Eur Acad Dermatol Venereol. 2018 Aug;32(8):1297-1304. doi: 10.1111/jdv.14926. Epub 2018 Jul 19.

PMID:
29524255
32.

Genetic polymorphisms associated with psoriasis and development of psoriatic arthritis in patients with psoriasis.

Loft ND, Skov L, Rasmussen MK, Gniadecki R, Dam TN, Brandslund I, Hoffmann HJ, Andersen MR, Dessau RB, Bergmann AC, Andersen NM, Abildtoft MK, Andersen PS, Hetland ML, Glintborg B, Bank S, Vogel U, Andersen V.

PLoS One. 2018 Feb 1;13(2):e0192010. doi: 10.1371/journal.pone.0192010. eCollection 2018.

33.

Correction to: Cancer associated fibroblasts (CAFs) are activated in cutaneous basal cell carcinoma and in the peritumoural skin.

Omland SH, Wettergren EE, Mollerup S, Asplund M, Mourier T, Hansen AJ, Gniadecki R.

BMC Cancer. 2018 Jan 30;18(1):111. doi: 10.1186/s12885-018-3987-4.

34.

Folliculotropism Does Not Affect Overall Survival in Mycosis Fungoides: Results from a Single-Center Cohort and Meta-Analysis.

Giberson M, Mourad A, Gniadecki R.

Dermatology. 2017;233(4):320-325. doi: 10.1159/000484203. Epub 2017 Nov 24. Review.

PMID:
29169156
35.

Safety, efficacy and drug survival of biologics and biosimilars for moderate-to-severe plaque psoriasis.

Egeberg A, Ottosen MB, Gniadecki R, Broesby-Olsen S, Dam TN, Bryld LE, Rasmussen MK, Skov L.

Br J Dermatol. 2018 Feb;178(2):509-519. doi: 10.1111/bjd.16102. Epub 2018 Jan 9.

PMID:
29094341
36.

Cancer associated fibroblasts (CAFs) are activated in cutaneous basal cell carcinoma and in the peritumoural skin.

Omland SH, Wettergren EE, Mollerup S, Asplund M, Mourier T, Hansen AJ, Gniadecki R.

BMC Cancer. 2017 Oct 7;17(1):675. doi: 10.1186/s12885-017-3663-0. Erratum in: BMC Cancer. 2018 Jan 30;18(1):111.

37.

Effectiveness and safety of secukinumab in 69 patients with moderate to severe plaque psoriasis: A retrospective multicenter study.

Schwensen JF, Clemmensen A, Sand C, Gniadecki R, Skov L, Zachariae C, Iversen L, Rasmussen M, Thomsen SF.

Dermatol Ther. 2017 Nov;30(6). doi: 10.1111/dth.12550. Epub 2017 Sep 14.

PMID:
28906051
38.

Early clinical manifestations of Sézary syndrome: A multicenter retrospective cohort study.

Mangold AR, Thompson AK, Davis MD, Saulite I, Cozzio A, Guenova E, Hodak E, Amitay-Laish I, Pujol RM, Pittelkow MR, Gniadecki R.

J Am Acad Dermatol. 2017 Oct;77(4):719-727. doi: 10.1016/j.jaad.2017.05.036. Epub 2017 Jul 11.

PMID:
28709694
39.

Associations between functional polymorphisms and response to biological treatment in Danish patients with psoriasis.

Loft ND, Skov L, Iversen L, Gniadecki R, Dam TN, Brandslund I, Hoffmann HJ, Andersen MR, Dessau RB, Bergmann AC, Andersen NM, Andersen PS, Bank S, Vogel U, Andersen V.

Pharmacogenomics J. 2018 May 22;18(3):494-500. doi: 10.1038/tpj.2017.31. Epub 2017 Jul 11.

PMID:
28696418
40.

[Mohs surgery for basal cell carcinoma].

Glud M, Omland SH, Paoli J, Gniadecki R.

Ugeskr Laeger. 2017 Feb 6;179(6). pii: V07160501. Review. Danish.

PMID:
28397683
41.

European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome - Update 2017.

Trautinger F, Eder J, Assaf C, Bagot M, Cozzio A, Dummer R, Gniadecki R, Klemke CD, Ortiz-Romero PL, Papadavid E, Pimpinelli N, Quaglino P, Ranki A, Scarisbrick J, Stadler R, Väkevä L, Vermeer MH, Whittaker S, Willemze R, Knobler R.

Eur J Cancer. 2017 May;77:57-74. doi: 10.1016/j.ejca.2017.02.027. Epub 2017 Mar 31. Review.

42.

Characteristics of patients receiving ustekinumab compared with secukinumab for treatment of moderate-to-severe plaque psoriasis - nationwide results from the DERMBIO registry.

Egeberg A, Iversen L, Gniadecki R, Hvid L, Dam TN, Bryld LE, Skov L.

J Eur Acad Dermatol Venereol. 2017 Jul;31(7):1183-1187. doi: 10.1111/jdv.14200. Epub 2017 Mar 29.

PMID:
28273375
43.

Psoralen with ultraviolet A-induced apoptosis of cutaneous lymphoma cell lines is augmented by type I interferons via the JAK1-STAT1 pathway.

Liszewski W, Naym DG, Biskup E, Gniadecki R.

Photodermatol Photoimmunol Photomed. 2017 May;33(3):164-171. doi: 10.1111/phpp.12302. Epub 2017 Apr 17.

PMID:
28196286
44.

A randomized, double-blind, placebo-controlled, dose-escalation first-in-man study (phase 0) to assess the safety and efficacy of topical cytosolic phospholipase A2 inhibitor, AVX001, in patients with mild to moderate plaque psoriasis.

Omland SH, Habicht A, Damsbo P, Wilms J, Johansen B, Gniadecki R.

J Eur Acad Dermatol Venereol. 2017 Jul;31(7):1161-1167. doi: 10.1111/jdv.14128. Epub 2017 Feb 17.

PMID:
28107559
45.

TP53 Gene Status Affects Survival in Advanced Mycosis Fungoides.

Wooler G, Melchior L, Ralfkiaer E, Rahbek Gjerdrum LM, Gniadecki R.

Front Med (Lausanne). 2016 Nov 11;3:51. eCollection 2016.

46.

Monopathogenic vs multipathogenic explanations of pemphigus pathophysiology.

Ahmed AR, Carrozzo M, Caux F, Cirillo N, Dmochowski M, Alonso AE, Gniadecki R, Hertl M, López-Zabalza MJ, Lotti R, Pincelli C, Pittelkow M, Schmidt E, Sinha AA, Sprecher E, Grando SA.

Exp Dermatol. 2016 Nov;25(11):839-846. doi: 10.1111/exd.13106. Review.

PMID:
27305362
47.

Small-molecule inhibitors of Ataxia Telangiectasia and Rad3 related kinase (ATR) sensitize lymphoma cells to UVA radiation.

Biskup E, Naym DG, Gniadecki R.

J Dermatol Sci. 2016 Dec;84(3):239-247. doi: 10.1016/j.jdermsci.2016.09.010. Epub 2016 Sep 16.

PMID:
27743911
48.

High diversity of the T-cell receptor repertoire of tumor-infiltrating lymphocytes in basal cell carcinoma.

Omland SH, Hamrouni A, Gniadecki R.

Exp Dermatol. 2017 May;26(5):454-456. doi: 10.1111/exd.13240. Epub 2017 Jan 19.

PMID:
27714856
49.

Ubiquitin-specific peptidase 2 as a potential link between microRNA-125b and psoriasis.

Wei T, Folkersen L, Biskup E, Xu N, Manfe V, Niazi O, Gniadecki R.

Br J Dermatol. 2017 Mar;176(3):723-731. doi: 10.1111/bjd.14916. Epub 2016 Dec 30.

PMID:
27479112
50.

Ubiquitin-specific protease 2 decreases p53-dependent apoptosis in cutaneous T-cell lymphoma.

Wei T, Biskup E, Gjerdrum LM, Niazi O, Ødum N, Gniadecki R.

Oncotarget. 2016 Jul 26;7(30):48391-48400. doi: 10.18632/oncotarget.10268.

Supplemental Content

Loading ...
Support Center